Ecofucin® for the prevention of vaginal microbiota dysbiosis — bacterial vaginosis and candidiasis amid the use of systemic antimicrobial therapy
<p> V.N. Kuzmin </p> <p> A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation </p> <p> <b>Aim: </b>to assess the efficacy and safety of Ecofucin<sup>®</sup> in patients after performing planned gyneco...
Main Author: | V.N. Kuzmin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LCC «Medicine-Inform»
2022-12-01
|
Series: | РМЖ. Мать и дитя |
Online Access: | http://wchjournal.com/upload/iblock/0ac/itxsl5r3xuwm0jvwc1ahykswd1awm9q1.pdf |
Similar Items
-
The modern approach to the etiology, pathogenesis, treatment and prevention of bacterial vaginosis and vaginal candidiasis
by: O A Pustotina
Published: (2015-06-01) -
Vaginal Biogenic Amines: Biomarkers of Bacterial Vaginosis or Precursors to Vaginal Dysbiosis?
by: Tiffanie Maree Nelson, et al.
Published: (2015-09-01) -
Vaginal microbiota in bacterial vaginosis. Aspects of diagnosis and therapy
by: A. M. Savicheva, et al.
Published: (2014-12-01) -
Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis
by: E.A. Markova
Published: (2020-09-01) -
Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis
by: Bingbing Xiao, et al.
Published: (2022-03-01)